Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation-Reference-Cited by-同舟云学术

Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation

Published:2007-07-18 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Akl Elie A,van Doormaal Frederiek F,Barba Maddalena,Kamath Ganesh,Kim Seo Young,Kuipers Saskia,Middeldorp Saskia,Yosuico Victor E D,Dickinson Heather O,Schünemann Holger

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006652/epdf/full

Reference69 articles.

1. A randomized clinical trial of combination chemotherapy with and without low molecular weight heparin in small cell lung cancer;Altinbas;Journal of Thrombosis and Haemostasis,2004

2. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS);Kakkar;Journal of Clinical Oncology,2004

3. The effect of low molecular weight heparin on survival in patients with advanced malignancy;Klerk;Journal of Clinical Oncology,2005

4. Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group;Lebeau;Cancer,1994

5. Low-Molecular-Weight-Heparin in Patients with Advanced Cancer: A Phase 3 Clinical Trial;Sideras;Mayoclinic Proceedings,2006

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboprophylaxis for inpatient with advanced cancer receiving palliative care: A retrospective study;European Journal of Haematology;2022-08-02

2. Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban;Cancer Medicine;2021-08-31

3. The Role of Platelet Cell Surface P-Selectin for the Direct Platelet-Tumor Cell Contact During Metastasis Formation in Human Tumors;Frontiers in Oncology;2021-03-15

4. Differential signaling patterns of stimulated bone marrow-derived dendritic cells under α1-antitrypsin-enriched conditions;Cellular Immunology;2021-03

5. Anti‐tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer;Journal of Cellular Physiology;2018-05-09